These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28973622)

  • 1. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults.
    Li D; Radulescu A; Shrestha RT; Root M; Karger AB; Killeen AA; Hodges JS; Fan SL; Ferguson A; Garg U; Sokoll LJ; Burmeister LA
    JAMA; 2017 Sep; 318(12):1150-1160. PubMed ID: 28973622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies.
    Lam L; Bagg W; Smith G; Chiu WW; Middleditch MJ; Lim JC; Kyle CV
    Thyroid; 2018 Aug; 28(8):1063-1067. PubMed ID: 29808739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS.
    Samarasinghe S; Meah F; Singh V; Basit A; Emanuele N; Emanuele MA; Mazhari A; Holmes EW
    Endocr Pract; 2017 Aug; 23(8):989-998. PubMed ID: 28534685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigation of Biotin Interference in Manual and Automated Immunoassays by Preconjugating Biotinylated Antibodies to the Streptavidin Surface as an Alternative to Biotin Depletion.
    Nelson HA; La'ulu SL; Lu J; Doyle K
    J Appl Lab Med; 2022 May; 7(3):762-775. PubMed ID: 35018420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic kidney failure and biotin: A combination inducing unusual results in thyroid and parathyroid investigations, report of 2 cases].
    Ranaivosoa MK; Ganel S; Agin A; Romain S; Parent X; Reix N
    Nephrol Ther; 2017 Dec; 13(7):553-558. PubMed ID: 29133077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biotin interference within interference suppressed immunoassays.
    Kabiri P; Weiskirchen R; van Helden J
    J Clin Lab Anal; 2021 Sep; 35(9):e23940. PubMed ID: 34346119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.
    Piketty ML; Prie D; Sedel F; Bernard D; Hercend C; Chanson P; Souberbielle JC
    Clin Chem Lab Med; 2017 May; 55(6):817-825. PubMed ID: 28222020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassay design and biotin interference.
    Dasgupta A
    Adv Clin Chem; 2022; 109():165-183. PubMed ID: 35953126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive assessment of biotin interference in immunoassays.
    Li J; Wagar EA; Meng QH
    Clin Chim Acta; 2018 Dec; 487():293-298. PubMed ID: 30296442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of biotin interference in thyroid function tests.
    Zhang Y; Wang R; Dong Y; Huang G; Ji B; Wang Q
    Medicine (Baltimore); 2020 Feb; 99(9):e19232. PubMed ID: 32118725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads.
    Yang J; Wiencek JR
    Clin Chim Acta; 2020 Jun; 505():130-135. PubMed ID: 32084383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
    Shimmaru K; Inami M; Hamaoka A; Fujiwara N; Morioka T; Emoto M; Kamei N
    Endocr J; 2023 Aug; 70(8):833-837. PubMed ID: 37331797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of anti-streptavidin antibodies: More common than we thought? In relation to six confirmed cases.
    Ricci V; Esteban MP; Sand G; Menises MM
    Clin Biochem; 2021 Apr; 90():62-65. PubMed ID: 33545112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference from anti-streptavidin antibody.
    Rulander NJ; Cardamone D; Senior M; Snyder PJ; Master SR
    Arch Pathol Lab Med; 2013 Aug; 137(8):1141-6. PubMed ID: 23899071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.
    Stieglitz HM; Korpi-Steiner N
    Clin Biochem; 2020 Jan; 75():53-61. PubMed ID: 31677994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat.
    Luong JHT; Male KB; Glennon JD
    Biotechnol Adv; 2019; 37(5):634-641. PubMed ID: 30872068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum biotin interference: A troublemaker in hormone immunoassays.
    Öncül Ü; Eminoğlu FT; Köse E; Doğan Ö; Özsu E; Aycan Z
    Clin Biochem; 2022 Jan; 99():97-102. PubMed ID: 34736903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fake news? Biotin interference in thyroid immunoassays.
    Koehler VF; Mann U; Nassour A; Mann WA
    Clin Chim Acta; 2018 Sep; 484():320-322. PubMed ID: 29856977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays.
    Trambas C; Lu Z; Yen T; Sikaris K
    Ann Clin Biochem; 2018 Mar; 55(2):216-226. PubMed ID: 28406314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AACC Guidance Document on Biotin Interference in Laboratory Tests.
    Li D; Ferguson A; Cervinski MA; Lynch KL; Kyle PB
    J Appl Lab Med; 2020 May; 5(3):575-587. PubMed ID: 32445355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.